In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse (lisdexamfetamine dimesylate) for the treatment of attention-deficit/hyperactivity disorder in people 6 years and older.
Read MoreIn response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse (lisdexamfetamine dimesylate) for the treatment of attention-deficit/hyperactivity disorder in people 6 years and older.
Read MoreSomething you probably don’t know about Agileana’s staff is that many of us are also skilled musicians. There are drummers, keyboardists, guitarists, and talented singers on our team. This should ...
Read MoreAttorney Arash Hashemi debunks legal misconceptions in engaging short videos. First episode on Miranda rights now available. Watch on YouTube, Instagram, and TikTok. Empower yourself with accurate legal knowledge.
Read More